Juice from Fructus Rosae Roxburghii normalizes blood lipids in mice with diet‐induced hyperlipidemia*(†)

Fructus Rosae Roxburghii (FRR) as a dietary supplement is considered to possess anti‐atherosclerosis (AS), and hyperlipidemia (HLP) is material basis for AS formation, so the effects and molecular mechanism of FRR on diet‐induced hyperlipidemic mice were explored. In Diet IV2 group, hepatic steatosis was significantly relieved; meanwhile, TC, TG, LDL‐C, HDL‐C, and ASI in serum were regulated to control level. Thirty‐seven DCEG in Diet I, Diet II, and Diet IV2 groups were obtained by RNA‐seq analysis. Relative mRNA levels were further determined by qRT‐PCR, of which 28 genes were matched with those detected by RNA‐seq. Ten DCEP were verified by targeted quantitative proteomic analysis, but expressive patterns of only six proteins were correlated with qRT‐PCR data. These DCEG and DCEP played important roles in regulating the biosynthesis of BAs and steroids, fatty acid metabolism, and LPO production. They might cooperatively regulate the function of HDL or RCT by PPAR signaling pathway under the FRR action. As we know, it is the first time the potential anti‐atherosclerotic mechanism of FRR regulating the blood lipids was explored.